In addition to hyperhomocysteinemia, Bhmt−/− mice show 48% lower liver SAM content, 21-fold-higher liver betaine, and histological evidence of liver steatosis compared to the Bhmt+/+ mice [4]. The gene discussed is BHMT; the disease is medical procedure.